Skip to main content

Peer Review reports

From: Chemotherapy versus personalized therapy for EGFR mutant lung adenocarcinoma resistance to EGFR-tyrosine kinase inhibitors: a retrospective dual-center study

Original Submission
10 Sep 2023 Submitted Original manuscript
12 Nov 2023 Reviewed Reviewer Report - Philip Bonomi
23 Nov 2023 Reviewed Reviewer Report
3 Dec 2023 Author responded Author comments - Gen Lin
Resubmission - Version 2
3 Dec 2023 Submitted Manuscript version 2
15 Jan 2024 Reviewed Reviewer Report
30 Jan 2024 Author responded Author comments - Gen Lin
Resubmission - Version 3
30 Jan 2024 Submitted Manuscript version 3
9 Feb 2024 Author responded Author comments - Gen Lin
Resubmission - Version 4
9 Feb 2024 Submitted Manuscript version 4
Publishing
12 Feb 2024 Editorially accepted
24 Feb 2024 Article published 10.1186/s12890-024-02905-1

You can find further information about peer review here.

Back to article page